Canasa Pac Interactions
There are 120 drugs known to interact with Canasa Pac (mesalamine), along with 2 disease interactions. Of the total drug interactions, 27 are major, 92 are moderate, and 1 is minor.
- View Canasa Pac disease interactions (2)
Medications known to interact with Canasa Pac
Note: Showing generic names only.
A
- acetohexamide
- acyclovir
- adefovir
- amikacin
- amikacin liposome
- amphotericin b
- amphotericin b cholesteryl sulfate
- amphotericin b lipid complex
- amphotericin b liposomal
- anisindione
- azathioprine
B
C
- capreomycin
- celecoxib
- chlorpropamide
- cidofovir
- cisplatin
- clofarabine
- colistimethate
- cyclosporine
- cytomegalovirus immune globulin
D
E
F
G
I
- ibandronate
- ibuprofen
- immune globulin intravenous
- immune globulin intravenous and subcutaneous
- indomethacin
- inotersen
- iobenguane I 131
- iodamide
- iodipamide
- iodixanol
- iohexol
- iomeprol
- iopamidol
- iopromide
- iothalamate
- ioversol
- ioxaglate
- ioxilan
K
L
M
- meclofenamate
- mefenamic acid
- meloxicam
- mercaptopurine
- methotrexate
- methoxyflurane
- metrizamide
- monomethyl fumarate
- moxetumomab pasudotox
N
O
P
R
- remdesivir
- repaglinide
- respiratory syncytial virus immune globulin
- rho (d) immune globulin
- rofecoxib
S
T
- tacrolimus
- telavancin
- telbivudine
- temsirolimus
- tenofovir
- tenofovir alafenamide
- thioguanine
- tobramycin
- tolazamide
- tolbutamide
- tolmetin
V
W
Z
Canasa Pac disease interactions
There are 2 disease interactions with Canasa Pac (mesalamine) which include:
More about Canasa Pac (mesalamine)
- Canasa Pac consumer information
- Compare alternatives
- Reviews (2)
- Side effects
- Dosage information
- During pregnancy
- Drug class: 5-aminosalicylates
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.